Author

A. Elsayed

Medizinische Hochschule Hannover

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biophysics· 1 Genetic & Genomic Medicine· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Approach:biophysical modeling· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Organism:human· 1

Frequent Co-Authors

A. Galbiati· 1 shared A. L. Bruel· 1 shared A. Zana· 1 shared Alireza SedaghatiD· 1 shared Anna Wiemers· 1 shared Barbara VonaiD· 1 shared Bernd AuberiD· 1 shared C. Phillipe· 1 shared

Activity by Year

2020-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Galbiati

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

XPOT Deficiency causes a human disorder through impaired tRNA nuclear export

Sandra v. Hardenberg, Indra Niehaus, Anna Wiemers, Tobias Rothoeft, K. Huang, Cassidy Petree, V. Schäffer, C. Phillipe, A. L. Bruel, Klaus Warnatz, Mina Zamani, R. Ahmadi, Alireza Sedaghat, Seiamak Bahram, Sahar Sadat Sedighzadeh, , Bernd Auber

This study identifies XPOT deficiency as a human disorder causing immune defects, hearing loss, and developmental issues through impaired tRNA nuclear export.

medRxiv · Feb 4, 2026 · PreprintGenetic & Genomic Medicine

A novel dimeric FAP-targeting small molecule-radio conjugate with high and prolonged tumour uptake

A. Galbiati, A. Zana, M. Bocci, J. Millul, A. Elsayed, J. Mock, D. Neri, S. Cazzamalli

This paper develops a dimeric FAP-targeting radioligand with prolonged tumour uptake and improved tumour-to-organ ratio, showing potent anti-tumour efficacy in preclinical models.

bioRxiv · Feb 21, 2022Pharmacology & Toxicology

A Ribosome Interaction Surface Sensitive to mRNA GCN Periodicity

K. Scopino, E. Williams, A. Elsayed, W. A. Barr, D. Krizanc, K. M. Thayer, M. P. Weir

The paper identifies a ribosome surface that interacts with mRNA GCN codons, showing sequence-specific hydrogen bonding that influences translation regulation.

bioRxiv · Apr 28, 2020Biophysics